Trane Technologies CEO sells 22,497 exercised shares

Rhea-AI Filing Summary

Trane Technologies plc Chair and CEO David S. Regnery exercised stock options covering 22,497 ordinary shares on September 2, 2025 at an exercise price of $62.5300 per share, then sold 22,497 ordinary shares at $410.0000 per share in a reported sale transaction the same day.

After these transactions, he directly held 123,712.941 ordinary shares. The filing notes that the transactions were executed pursuant to a Rule 10b5-1 Plan adopted on June 2, 2025.

Insights

Corporate Governance Expert

TL;DR: CEO executed a 10b5-1 plan sale after exercising vested options, reducing beneficial ownership by 22,497 shares.

The filing shows a routine, preplanned insider transaction under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when properly adopted. The CEO exercised options priced at $62.53 and sold the same number of shares at a reported price of $410, lowering his beneficial stake from 146,209.941 to 123,712.941 shares. This pattern—exercise followed by sale under a 10b5-1 plan—is common for liquidity and tax planning and is documented with vesting commencing in 2018. No amendment or other governance irregularities are evident in the form.

Securities Analyst

TL;DR: Insider exercised options and sold identical shares under a documented plan; transaction is material to insider holdings but not to company fundamentals.

The report quantifies a reduction of ~15.4% of the reported pre-transaction beneficial holdings (22,497 of 146,209.941). The exercise price of $62.53 and reported sale price of $410 imply a large per-share spread for the insider, though the Form 4 does not provide aggregate proceeds or reasons beyond the 10b5-1 plan reference. From a market-impact perspective, the disclosed sale size is modest relative to a large-cap issuer but is clearly material to the reporting person’s ownership. No changes to compensation structure or unusual derivative positions are disclosed.

Insider Trade Summary

Exercise and Sale: 22,497 shares ($7.82M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Regnery David S

Role Chair and CEO

Sold 22,497 shs ($9.22M)

Approx. gross sale proceeds $9.22M

Approx. exercise cost $1.41M

Approx. pre-tax spread $7.82M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	22,497	$0.00	$0.00
Exercise	Ordinary Shares	22,497	$62.53	$1.41M
Sale	Ordinary Shares	22,497	$410.00	$9.22M

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 123,712.941 shares (Direct)

Footnotes (2)

1. F1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 2, 2025.
2. F2. The stock option vested in three (3) pro rata annual installments beginning on February 7, 2018.

Key Figures

Options exercised: 22,497 shares Exercise price: $62.5300 per share Shares sold: 22,497 shares +4 more

7 metrics

Options exercised 22,497 shares Stock options exercised on 2025-09-02

Exercise price $62.5300 per share Exercise price of the Stock Option (Right to Buy)

Shares sold 22,497 shares Ordinary shares sold on 2025-09-02

Sale price $410.0000 per share Per-share price in the reported sale transaction

Post-transaction holdings 123,712.941 shares Ordinary shares held directly after the transactions

Option expiration date 2027-02-06 Original expiration date of the exercised option grant

Rule 10b5-1 plan adoption date June 2, 2025 Date the reporting person adopted the Rule 10b5-1 Plan

Key Terms

Rule 10b5-1 Plan, Stock Option (Right to Buy), Ordinary Shares, Exercise or conversion of derivative security

4 terms

Rule 10b5-1 Plan regulatory

"Transaction executed pursuant to a Rule 10b5-1 Plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

Stock Option (Right to Buy) financial

"security_title listed as Stock Option (Right to Buy)"

Ordinary Shares financial

"underlying_security_title shown as Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Exercise or conversion of derivative security financial

"transaction code description Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Trane Technologies (TT) CEO David Regnery report?

David S. Regnery reported an option exercise and matching share sale. He exercised stock options for 22,497 ordinary shares at $62.5300 per share and sold 22,497 shares at $410.0000 per share on September 2, 2025 under a Rule 10b5-1 plan.

How many Trane Technologies (TT) shares did David Regnery sell and at what price?

He sold 22,497 ordinary shares of Trane Technologies at a price of $410.0000 per share. The sale occurred on September 2, 2025 and followed an option exercise for the same number of shares reported in the same Form 4 filing.

What stock options did David Regnery exercise in Trane Technologies (TT)?

He exercised a Stock Option (Right to Buy) for 22,497 underlying ordinary shares at an exercise price of $62.5300 per share. The option was scheduled to expire on February 6, 2027 and had vested in three pro rata annual installments beginning February 7, 2018.

How many Trane Technologies (TT) shares does David Regnery hold after this transaction?

After the reported transactions, David S. Regnery directly holds 123,712.941 ordinary shares of Trane Technologies. This figure reflects his post-transaction ownership as stated in the filing’s canonical holdings section and represents his reported direct equity stake.

Were David Regnery’s Trane Technologies (TT) trades made under a Rule 10b5-1 plan?

Yes. A footnote states the transaction was executed under a Rule 10b5-1 Plan adopted by David S. Regnery on June 2, 2025. Such plans are pre-arranged trading programs that can reduce the informational significance of transaction timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regnery David S

(Last) (First) (Middle)

C/O TRANE TECHNOLOGIES COMPANY LLC

800-E BEATY STREET

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trane Technologies plc [ TT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/02/2025		M		22,497	A	$62.53	146,209.941	D
Ordinary Shares	09/02/2025		S		22,497(1)	D	$410	123,712.941	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$62.53	09/02/2025		M			22,497	(2)	02/06/2027	Ordinary Shares	22,497	$0	0	D

Explanation of Responses:

1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 2, 2025.

2. The stock option vested in three (3) pro rata annual installments beginning on February 7, 2018.

Remarks:

	/s/ Eric R. Waller, Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.